Searched for
MERCK COVID MEDICINE
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- European Union's drug regulator green lights Pfizer's COVID-19 pillThe endorsement by the European Medicines Agency (EMA) allows EU member states to deploy the drug after the regulator gave guidance for its...
- EU regulator set to rule on Pfizer COVID pill by end-Jan, ahead of Merck - sourceThe EMA's review of Merck's pill, developed with Ridgeback Biotherapeutics, is taking longer than Pfizer's because Merck released trial dat...
- Natco Pharma signs pact with MPP to sell Molnupiravir capsulesNatco Pharma has signed a non-exclusive license agreement with the Medicines Patent Pool (MPP), Switzerland to manufacture and sell Molnupi...
- Good news on Covid therapy frontExperience with the Omicron variant so far makes clear that while vaccines are critical for reducing the virulence of the disease, therapie...
- Pfizer pill becomes 1st US-authorized home COVID treatmentData from Pfizer's clinical trial showed its two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in pati...
- Canada reports 15 cases of Omicron variant, government pushes for booster vaccineThe federal government said it backed a recommendation of a national advisory board on immunizations that all adults above 50 should receiv...
- COVID antiviral drug Molnupiravir efficacy against hospitalization or death drops to 30% compared to placebo groupThe analysis of latest data on efficacy is much less than the previous interim analysis announced by the company which was based on data fr...
- Dr Reddy’s, Merck’s Covid pill partner in India, sees a short-lived boomAnd this is despite Dr Reddy’s, one of India’s largest drugmakers, gearing to export Sputnik shots next year and expecting regulatory nod t...
- Pfizer to allow generic versions of its COVID-19 pill in 95 countriesThe voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified ...
- With UK nod, Merck drug becomes world's 1st pill for Covid treatmentThe MHRA recommended the use of Covid-19 drug molnupiravir as soon as possible following a positive Covid-19 test and within five days of s...
- UK drug regulatory approves COVID antiviral drug MolnupiravirThe risk factors include obesity, older age (>60 years), diabetes mellitus, or heart disease. MHRA recommended the use of Molnupiravir as s...
- UK authorizes Merck's coronavirus pill, the first shown to be effective at treating COVID-19The pill was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe...
- Natco Pharma, Hetero seek marketing authorisation for anti-Covid drug molnupiravirNatco has conducted Phase III trials of molnupiravir and submitted the trial results to the drug regulator this month. "We have submitted p...
- India's Everest Organics starts making ingredient for Merck's COVID-19 pillThe Indian bulk drugs manufacturer joins Divi's Laboratories Ltd as an API maker for Merck's experimental oral drug. Merck has separately e...
- Two Indian drugmakers seek to end trials of Merck's antiviral drug for moderate COVID-19The two Indian drugmakers, Aurobindo Pharma and MSN Laboratories plan to continue late-stage trails of the drug for those with mild COVID-1...
- What you need to know about Merck’s new COVID treatment medicineThe pills are meant for people who are sick with COVID but are not in the hospital.
- MSD in talks with Medicines Patent Pool for additional licenses for molnupiravirMSD entered into a voluntary licensing agreement with five Indian drug makers including Sun Pharma, Cipla, Dr. Reddy’s, Emcure and Hetero f...
- MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufactur...
- Oral Covid treatment yields promising trial data: DrugmakersIn January, Merck halted work on two Covid vaccine candidates but has pressed on with research into two products to treat the disease, incl...
Load More
